Table 7:
Detailed evaluation for secondary causes of hypertension8
| Clinical diagnosis | Confirmatory evaluation |
|---|---|
| Glomerulonephritis |
Serum C3, C4, ASO Autoantibodies (ANA/anti dsDNA/ANCA) Renal biopsy |
| Reflux nephropathy |
Micturating cystourethrogram Nuclear scan (DMSA/MAG3) |
| Renovascular disease |
Plasma renin/aldosterone levels Kidney doppler (low sensitivity) CT/MR renal angiography (>95% sensitive) Digital subtraction angiography – Gold standard |
| Pheochromocytoma |
Urine and plasma metanephrines MIBG scan CT/MRI abdomen Arteriography and caval catecholamine sampling |
| Hyperthyroidism or hypothyroidism | Thyroid stimulating hormone, free T4 and free T3 |
|
Endocrine causes Cushings syndrome Primary aldosteronism |
Overnight dexamethasone suppression test, 24 hour urinary free cortisol Plasma aldosterone renin ratio |
| Coarctation of aorta | Echocardiogram |
| Neuroblastoma | Vanillylmandelic acid (VMA), homovanillic acid (HMA) |
| Monogenic Hypertension |
Aldosterone and renin levels Genetic testing |
ASO: Antistreptolysin O, ANA: Antinuclear antibody, dsDNA: Double-stranded deoxyribonucleic acid, ANCA: Anti-neutrophil cytoplasmic antibody, DMSA: Dimercaptosuccinic acid, MAG3: Mercaptuacetyltriglycine, CT: Computed tomography, MR: Magnetic resonance, MIBG: Metaiodobenzylguanidine, MRI: Magnetic resonance imaging